发明名称 HIV PROTEASE INHIBITING COMPOUND
摘要 <P>PROBLEM TO BE SOLVED: To provide an improved HIV protease inhibitor that is very potent, that has minimal side-effect and is effective against resistance strains of HIV. <P>SOLUTION: A compound represented by formula (I) or a pharmaceutically acceptable salt or stereoisomer thereof are disclosed. (in formula, A denotes an acetyl group substituted with a specified substituent, R<SP POS="POST">1</SP>, R<SP POS="POST">2</SP>, R<SP POS="POST">3</SP>and R<SP POS="POST">6</SP>each independently denotes alkyl, alkenyl, cycloalkyl, cycloalkenyl, heterocycle, aryl, heteroaryl or the like and R<SP POS="POST">4</SP>denotes hydrogen and R<SP POS="POST">5</SP>denotes OR<SP POS="POST">16</SP>or R<SP POS="POST">5</SP>denotes hydrogen and R<SP POS="POST">4</SP>denotes OR<SP POS="POST">16</SP>, or R<SP POS="POST">4</SP>and R<SP POS="POST">5</SP>denote -OR<SP POS="POST">16</SP>and R<SP POS="POST">16</SP>denotes hydrogen or a specifics substituent). <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012162526(A) 申请公布日期 2012.08.30
申请号 JP20120049246 申请日期 2012.03.06
申请人 ABBOTT LAB 发明人 DEGOEY DAVID A;FLENTGE CHARLES A;FLOSI WILLIAM J;GRAMPOVNIK DAVID J;KEMPF DALE J;KLEIN LARRY L;YEUNG MING C;RANDOLPH JOHN T;WANG XIU C;YU SU
分类号 C07C311/16;A61K31/27;A61K31/381;A61K31/40;A61K31/4178;A61K31/42;A61K31/426;A61K31/427;A61K31/4418;A61K31/4439;A61K31/444;A61K31/4709;A61K31/661;A61K45/00;A61P31/18;A61P43/00;C07D207/12;C07D213/30;C07D213/40;C07D233/64;C07D261/12;C07D333/40;C07D401/04;C07D401/06;C07D401/12;C07D401/14;C07D403/06;C07D413/04;C07D417/04;C07D417/06;C07D417/14;C07D471/04;C07D493/04;C07F9/6506 主分类号 C07C311/16
代理机构 代理人
主权项
地址